Clinical development in the management of lupus in the neonate, child, and adolescent

Current Opinion in Rheumatology

Volumn 10, Issue 5, 1998, Pages 431-434

  Szer, Ilona S ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISONE;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; CHILD; CONGENITAL HEART BLOCK; HUMAN; INFANT; NEWBORN; NEWBORN DISEASE; PEDIATRICS; PRIORITY JOURNAL; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; CHILD, PRESCHOOL; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0031711227     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199809000-00006     Document Type: Short Survey

References (9)

1. Baca V, Garcia-Ramirez R, Ramirez-Lacayo M, Marquez-Enriquez L, Martinez I, Lavalle C: Cerebral infarction and antiphospholipid syndrome in children. J Rheumatol 1996, 23:1428-1431.
2. Edlinger G, Gallistl S, Muntean W: Lupus anticoagulant and factor XII activity in children with prolonged PTT. Thromb Res 1996, 83:403-404.
3. Becton DL, Stine KC: Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome. J Pediatr 1997, 130:998-1000.
4. Massengill SF, Hedrick C, Ayoub EM, Sleasman JW, Kao KJ: Antiphospholipid antibodies in pediatric lupus nephritis. Am J Kidney Dis 1997, 29:355-361.
5. Silverman E: What's new in the treatment of pediatric SLE. J Rheumatol 1996, 23:1657-1660.
6. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A: Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996, 7:924-929.
7. Buyon J: Neonatal lupus: bedside to bench and back. Scand J Rheumatol 1996, 25:271-276.
8. Buyon J: Neonatal lupus. Curr Opin Rheumatol 1996, 8:485-490.
9. Horsfall AC, Li JM, Maini RN: Placental and fetal cardiac laminin are targets for cross-reacting autoantibodies from mothers of children with congenital heart block. J Autoimmunity 1996, 4:561-568.